Pinned Tweet
#OpenUpYourScience with #EHJOpen
Lung ultrasound in ambulatory adults with HFpEF: Association between pulmonary congestion and one-year outcomes
@ESC_Journals @ProfMagnusBack @SaDeRosa78 academic.oup.com/ehjopen/articl…
Lung ultrasound in ambulatory adults with HFpEF: Association between pulmonary congestion and one-year outcomes
@ESC_Journals @ProfMagnusBack @SaDeRosa78 academic.oup.com/ehjopen/articl…
0
1
3
166
#OpenUpYourScience with #EHJOpen!
Challenges in Left Bundle Branch Area Pacing in Children and Congenital Heart Disease: Technical Limitations, Diagnostic Pitfalls, and Physiologic Insights
@ProfMagnusBack @ESC_Journals @SaDeRosa78 academic.oup.com/ehjopen/articl…
Challenges in Left Bundle Branch Area Pacing in Children and Congenital Heart Disease: Technical Limitations, Diagnostic Pitfalls, and Physiologic Insights
@ProfMagnusBack @ESC_Journals @SaDeRosa78 academic.oup.com/ehjopen/articl…
0
0
2
216
EHJOpen Editor-in-Chief retweeted
#OpenUpYourScience with #EHJOpen!
Comparing two distinct costing models for health economics of heart failure within a Swedish population-based cohort
@ESC_Lavinia @ProfMagnusBack academic.oup.com/ehjopen/articl…
Comparing two distinct costing models for health economics of heart failure within a Swedish population-based cohort
@ESC_Lavinia @ProfMagnusBack academic.oup.com/ehjopen/articl…
0
1
1
146
#OpenUpYourScience with #EHJOpen: check the latest data on Congenital Heart Disease!
Transition from Paediatric to Adult Congenital Heart Disease Care is not Just a challenge, but a real opportunity to improve the care of our patients!
#OpenUpYourScience
@ESC_Lavinia @ProfMagnusBack
@WGACHDChair @saramoscatelli7 academic.oup.com/ehjopen/articl…
1
1
3
219
Read this month's Editor choice:
Creatinine compared to Cystatin C: impact on Clinical Outcomes in #AtrialFibrillation
#OpenUpYourScience
@ESC_Journals @ProfMagnusBack @SaDeRosa78 @SilCastelletti academic.oup.com/ehjopen/articl…
Creatinine compared to Cystatin C: impact on Clinical Outcomes in #AtrialFibrillation
#OpenUpYourScience
@ESC_Journals @ProfMagnusBack @SaDeRosa78 @SilCastelletti academic.oup.com/ehjopen/articl…
0
0
6
299
EHJOpen Editor-in-Chief retweeted
Semaglutide protects the heart but we still don't fully know how. #SELECT mediation analysis: classic risk factors explain only half the benefit. Read more in #EHJ.
doi.org/10.1093/eurhea…
#cardiotwitter @ESC_Journals @escardio
doi.org/10.1093/eurhea…
#cardiotwitter @ESC_Journals @escardio
3
29
100
4,722
EHJOpen Editor-in-Chief retweeted
Left Ventricular Assist Device: Balancing Technological Excellence and Therapeutic Challenges!
#EHJ #heart #failure #mechanical #pump #cardiotwitter @ESC_Journals @escardio
ow.ly/TzNO50ZRRmw
#EHJ #heart #failure #mechanical #pump #cardiotwitter @ESC_Journals @escardio
ow.ly/TzNO50ZRRmw
1
16
46
2,551
EHJOpen Editor-in-Chief retweeted
Celebrating world heart day at @SCAI I3 mumbai meeting in India- the butter chicken and paneer will do wonders for my cv risk 😜😜
13
5
107
13,085
Not all ectopy carries the same weight—chamber-specific risk assessment is key in #ACHD!
Read the latest data published in #EHJOpen simultaneously with its presentation at #ESCCongress! 🫀 #Arrhythmia #CardioTwitter
@ESC_Lavinia @ProfMagnusBack @SaDeRosa78
doi.org/10.1093/ehjope…
Read the latest data published in #EHJOpen simultaneously with its presentation at #ESCCongress! 🫀 #Arrhythmia #CardioTwitter
@ESC_Lavinia @ProfMagnusBack @SaDeRosa78
doi.org/10.1093/ehjope…
0
2
3
415
EHJOpen Editor-in-Chief retweeted
Lowering cumulative LDL-C exposure: the case for early treatment. Read more in EHJ.
doi.org/10.1093/eurhea…
#LDLC #CholesterolManagement #EarlyTreatment #LipidLowering #CardiovascularHealth #EHJ #Cardiology @escardio @ESC_Journals
doi.org/10.1093/eurhea…
#LDLC #CholesterolManagement #EarlyTreatment #LipidLowering #CardiovascularHealth #EHJ #Cardiology @escardio @ESC_Journals
2
28
75
6,261
EHJOpen Editor-in-Chief retweeted
The new 2026 ESC Guidelines for the management of cardiovascular disease and chronic kidney disease are now available on EHJ. In collaboration with the European Renal Association (ERA): Developed by the task force on the management of cardiovascular disease and chronic kidney Society of Cardiology (ESC).
doi.org/10.1093/eurhea…
#ESC2026Guidelines #CardiovascularHealth #ChronicKidneyDisease #MedicalGuidelines2026 #CardioRenalCare @escardio @ESC_Journals
doi.org/10.1093/eurhea…
#ESC2026Guidelines #CardiovascularHealth #ChronicKidneyDisease #MedicalGuidelines2026 #CardioRenalCare @escardio @ESC_Journals
1
11
28
3,060
EHJOpen Editor-in-Chief retweeted
Did you pack your sport apparel in your suitcase to the #ESCCongress? Take a look at this month's Editor choice on #EHJOpen: association of self-reported sports volume and discipline with atrial arrhythmia prevalence in middle-aged males
@ESC_Lavinia
academic.oup.com/ehjopen/articl…
0
1
3
151
Did you pack your sport apparel in your suitcase to the #ESCCongress? Take a look at this month's Editor choice on #EHJOpen: association of self-reported sports volume and discipline with atrial arrhythmia prevalence in middle-aged males
@ESC_Lavinia
academic.oup.com/ehjopen/articl…
@ESC_Lavinia
academic.oup.com/ehjopen/articl…
0
0
3
306
EHJOpen Editor-in-Chief retweeted
After all, a non-inferiority margin is just another imaginary line... CHAMPION-AF and CLOSURE-AF reconciled #LAAC: read the viewpoint in #EHJ
CHAMPION-AF and CLOSURE-AF: reconciling contrasting results. Read this viewpoint about left atrial appendage closure #LAAC in #EHJ
👉 ow.ly/1HrK50ZFXkg
@RoccoMontone @ehj_ed
0
1
4
166
EHJOpen Editor-in-Chief retweeted
#ACE inhibitors or #ARBs in #patients at high or very high #cardiovascular risk without #heartfailure: is the answer obvious?
Great collaboration on this Editorial in #EHJOpen of @escardio with @CarlLavie31733 💪
@ehjopen @SaDeRosa78
academic.oup.com/ehjopen/articl…
Great collaboration on this Editorial in #EHJOpen of @escardio with @CarlLavie31733 💪
@ehjopen @SaDeRosa78
academic.oup.com/ehjopen/articl…
0
2
10
472
Advance articles reinforce our commitment to rigorous, transparent, and fully accessible cardiovascular science.
Read the latest on intracoronary imaging: academic.oup.com/ehjopen/advanc…
#OpenUpYourScience
@ESC_Lavinia @ProfMagnusBack @SaDeRosa78
Read the latest on intracoronary imaging: academic.oup.com/ehjopen/advanc…
#OpenUpYourScience
@ESC_Lavinia @ProfMagnusBack @SaDeRosa78
Can the benefit of IVUS-guided PCI be influenced by how the angiography control arm is optimized?
We explored a “hidden IVUS effect” in contemporary trials.
#IVUS may shape modern #PCI even when not directly used.
academic.oup.com/ehjopen/advanc…
@SaDeRosa78 @DaniTore74 @Y_Abdelwahed
0
1
5
851
The ESC journal family continues to grow in quality and reach with a special milestone: #EHJOpen has received its first IF: a strong signal for the authors who trust our mission.
Proud to stand alongside all ESC journals advancing rigorous, global research.
#OpenUpYourScience
Proud to stand alongside all ESC journals advancing rigorous, global research.
#OpenUpYourScience
2025 Impact Factors just released!
Congratulations to the Editors-in-Chief and their teams for their outstanding contribution to the @ESC_Journals Family. This year highlights the exceptional performance of the European Heart Journal, as well as the first Impact Factor for EHJ – ant milestone.
Discover our new Impact Factors ow.ly/k2ml50ZfSZw
@RoccoMontone @ehj_ed @ehjopen #EHJ #EHJOpen
1
3
9
2,073
Remarkable result from Clarivate: #OpenUpYourScience with #EHJOpen!
Proud to share #EHJOpen's first IF: 4.3.
A remarkable step for a young journal built on quality, transparency, and a strong commitment to Open Science. Grateful to be part of this journey, excited for what’s ahead.
#OpenUpYourScience
@ESC_Lavinia @maciejbanach @maciejbanach
0
1
7
434
EHJOpen Editor-in-Chief retweeted
#EHJOpen's first Impact Factor is 4.3!
A milestone that reflects rigorous science, transparent processes, and the strength of our global CV community that motivates us to advancing high‑quality #OpenAccess research.
#OpenUpYourScience
@ESC_Journals @ProfMagnusBack @SaDeRosa78
0
1
2
108
#EHJOpen's first Impact Factor is 4.3!
A milestone that reflects rigorous science, transparent processes, and the strength of our global CV community that motivates us to advancing high‑quality #OpenAccess research.
#OpenUpYourScience
@ESC_Journals @ProfMagnusBack @SaDeRosa78
A milestone that reflects rigorous science, transparent processes, and the strength of our global CV community that motivates us to advancing high‑quality #OpenAccess research.
#OpenUpYourScience
@ESC_Journals @ProfMagnusBack @SaDeRosa78
2
4
12
555

















